Healthcare Holding Schweiz Expands Portfolio with Effectum CH-Rep Acquisition

Healthcare Holding Schweiz Expands Its Footprint with Effectum CH-Rep Acquisition

Healthcare Holding Schweiz AG, a leading provider and distributor of medical technology in Switzerland, has made significant strides in the marketplace with its recent acquisition of Effectum CH-Rep AG. The successful acquisition, finalized on March 17, 2025, relies on a strategic Carve-Out of all services connected with Effectum Medical AG's Swiss representation (CH-REP).

This acquisition presents an instrumental shift for Healthcare Holding Schweiz, as it aligns with the Medical Devices Ordinance (MedDO SR 812.213) that necessitates companies outside Switzerland to designate a CH-REP to distribute their products domestically. This move not only reinforces Healthcare Holding's commitment to regulatory compliance but also positions the company as a more comprehensive partner for global medical device manufacturers looking to enter the Swiss market.

Fabio Fagagnini, CEO of Healthcare Holding Schweiz AG, expressed enthusiasm about the acquisition, noting, “With Effectum CH-Rep, we expand our service portfolio to include the role of the Swiss authorized representative, allowing our sales representatives to focus even more on innovative products and exceptional customer service while meeting regulatory requirements professionally.”

Kim Züger, who is now the Head of Quality Management and Regulatory Affairs at Effectum CH-Rep, highlighted the critical importance of regulatory compliance. “Providing this service not only for our Healthcare Holding Schweiz suppliers but for a broader range of manufacturers showcases our professionalism and quality standards,” she stated.

The Effectum CH-Rep AG, located in Olten, acts as a bridge for foreign medical device manufacturers seeking to access the Swiss market. By fulfilling responsibilities such as ensuring adherence to Swiss registration requirements and collaborating with Swissmedic for preventive measures, Effectum CH-Rep plays a pivotal role in providing foreign manufacturers with essential local support.

The firm will cater to various needs, such as providing a responsible person for regulatory compliance (PRRC) and maintaining access to technical documentation, along with reporting incidents and complaints to ensure thorough communication channels within the regulatory landscape.

Michael Eggimann, a board member of Effectum Medical AG and responsible for the sale, stated that he has profound trust in Fabio Fagagnini and his team’s capabilities, emphasizing that, “This transfer allows us to concentrate fully on the development and distribution of our Legal Manufacturing offerings, as well as our innovative plug-and-play quality management systems.”

Healthcare Holding Schweiz AG: A Leader in Medical Technology

Healthcare Holding Schweiz AG is recognized as a leading provider in medical technology products and services in the Swiss landscape. The firm, located in Baar, has an ambitious growth strategy that includes acquisitions, partnerships, and organic growth. It focuses on operational excellence, aiming to integrate technological solutions to streamline processes.

The proactive approach in fostering innovation and ensuring customer satisfaction has positioned Healthcare Holding as a market leader. The management team, which is fully invested in the company, showcases a dynamic group of entrepreneurs dedicated to driving the company forward with agile and responsive leadership.

Driven by the principles of quality and professionalism, Healthcare Holding and its subsidiaries are committed to establishing high service standards to benefit their clients and the broader healthcare sector in Switzerland.

Winterberg Advisory GmbH: The Strategic Partner

The acquisition was facilitated by Winterberg Advisory GmbH, which operates as an independent family office focused on investments in small and mid-sized enterprises across the German-speaking region. Winterberg Group AG is responsible for managing various private equity funds and plays a critical role in guiding Healthcare Holding in its strategic endeavors.

This acquisition not only augments Healthcare Holding's market position but also reinforces its capability to provide a complete suite of services to its clients, thereby supporting the future growth of the Swiss healthcare technology sector. Interested parties can learn more about Effectum CH-Rep AG and Healthcare Holding Schweiz AG by visiting their respective websites for further information on their comprehensive service offerings.